Liu Shijin: To expand consumption, we should manage from the source, and give priority to improving basic public services and consumption of low-and middle-income groups. Liu Shijin, deputy director of the 13th Chinese People's Political Consultative Conference Economic Commission and former deputy director of the the State Council Development Research Center, pointed out in his speech at the main forum of the 2024 Southern Finance and Economics International Forum that the macro-economy is picking up, but it is also facing the increasing pressure of insufficient total demand, especially insufficient consumer demand, and the focus of which is insufficient service consumption. We should give priority to improving basic public services and the consumption environment of low-and middle-income groups through "source governance" to promote the integrated development of urban and rural areas. On the basis of short-term stimulus policies, combined with medium-and long-term reforms, we will solve the institutional problems that restrict the expansion of consumption and help China's economy achieve high-quality development. "At present, it is necessary to distinguish the problems caused by insufficient demand from the causes of insufficient demand." Liu Shijin pointed out that from the perspective of international comparison, the lack of consumption demand in China at this stage is a structural deviation. In Liu Shijin's view, it is necessary to identify the key points or pain points in expanding consumer demand at this stage. First, service consumption based on basic public services, including education, medical and health care, affordable housing, social security, culture, sports and entertainment, financial services, transportation and communication; Second, the middle and low-income class with migrant workers as the focus; Third, people-centered, urbanization and urban-rural integration. (21 Finance)U.S. and cloth oil fell 0.3 USD in short term, and now they are reported at 70.08 USD/barrel and 73.50 USD/barrel respectively.European Commission President: Romania and Bulgaria have become full members of the Schengen area. European Commission President Ursula von der Leyen said on social media that Romania and Bulgaria have become full members of the Schengen area.
Weilai Li Bin: R&D investment is in basic research. Weilai's R&D expenses for Le Dao are far less than Xiaomi's R&D expenses for Xiaomi Automobile. (Sina Technology)The Environmental Protection Department of the National Development and Reform Commission organized the liaison meeting of the coordination mechanism of cleaner production promotion departments in 2024. On the afternoon of December 10th, the Environmental Protection Department of the National Development and Reform Commission organized the liaison meeting of the coordination mechanism of cleaner production promotion departments in 2024 to sort out and summarize the latest progress, existing problems and difficulties in the implementation of cleaner production in 2024, study the key tasks in 2025, and promote the completion of the objectives and tasks of the Tenth Five-Year Plan.Japan's Shimane nuclear power plant operating company said that there was no abnormality in the reactor water level gauge of Unit 2, which was previously misjudged. Japan's China Electric Power Company conducted an investigation on the report that the reactor water level gauge of Unit 2 of Shimane nuclear power plant was once abnormal, and the results showed that there was no abnormality. The company said that the value displayed by the instrument was normal, but the operator misunderstood the data and misjudged it as abnormal. Earlier in the day, China Electric Power Company said that several water level meters failed to work in Unit 2 of Shimane Nuclear Power Plant that morning. The water level gauge is used to monitor the water level when a major accident occurs.
Li Ka-shing's H-share shareholding in China Postal Savings Bank decreased from 5.07% to 4.96%.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Zhongyuan Expressway: The toll revenue in November was 373 million yuan. Zhongyuan Expressway announced that the toll revenue in November 2024 was 373 million yuan.
Strategy guide 12-13
Strategy guide
12-13